AOXING PHARMACEUTICAL COMPANY, INC. - FORM 10-K - EX-23.2 - CONSENT OF PARITZ & COMPANY, P.A. - October 15, 2012

Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - AOXING PHARMACEUTICAL COMPANY, INC.Financial_Report.xls
EX-32.1 - CERTIFICATE OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C.SS.1350. - AOXING PHARMACEUTICAL COMPANY, INC.aoxing10kexh321.htm
EX-31.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002. - AOXING PHARMACEUTICAL COMPANY, INC.aoxing10kexh312.htm
EX-32.2 - CERTIFICATE OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C.SS.1350. - AOXING PHARMACEUTICAL COMPANY, INC.aoxing10kexh322.htm
EX-31.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002. - AOXING PHARMACEUTICAL COMPANY, INC.aoxing10kexh311.htm
EX-21.1 - LIST OF SUBSIDIARIES - AOXING PHARMACEUTICAL COMPANY, INC.aoxing10kexh211.htm
EX-23.1 - CONSENT OF BDO CHINA DAHUA CPA CO., LTD. - AOXING PHARMACEUTICAL COMPANY, INC.aoxing10kexh231.htm
10-K - AOXING PHARMACEUTICAL COMPANY, INC. 10K 2012-06-30 - AOXING PHARMACEUTICAL COMPANY, INC.aoxing10k.htm
Exhibit 23.2
 
 
 
 
 
Consent of Independent Registered Public Accounting Firm



The Board of Director and Stockholders
Aoxing Pharmaceutical Company, Inc. and subsidiaries

We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (No. 333-177641) of Aoxing Pharmaceutical Company, Inc. and subsidiaries of our report dated September 27, 2011, except for Note 2 and Note 14 which are dated September 21, 2012 relating to the consolidated financial statements of Aoxing Pharmaceutical Company, Inc. and subsidiaries for the year ended June 30, 2011, which appear in this Form 10-K.


Paritz & Company, P.A.
Hackensack, New Jersey
October 15, 2012

AOXING PHARMACEUTICAL COMPANY, INC. Reports